Revised National Tuberculosis Control Programme

Revised National Tuberculosis Control Programme
Name	Revised National Tuberculosis Control Programme
Established	1997
Jurisdiction	India
Headquarters	New Delhi
Parent agency	Ministry of Health and Family Welfare

Revised National Tuberculosis Control Programme

The Revised National Tuberculosis Control Programme was India’s principal public health initiative to control tuberculosis through standardized case detection and directly observed treatment. Launched in 1997, the programme aligned national policy with international norms promoted by World Health Organization, World Bank, and agencies such as United Kingdom Department for International Development and Bill & Melinda Gates Foundation. It integrated existing national structures including the Ministry of Health and Family Welfare, state health directorates, and partners like Indian Council of Medical Research and National Institute of Tuberculosis and Respiratory Diseases.

History and Evolution

The programme evolved from earlier initiatives such as the National Tuberculosis Programme and global campaigns influenced by the Alma-Ata Declaration and the International Union Against Tuberculosis and Lung Disease. Policy adoption drew on guidance from World Health Organization’s DOTS strategy and financing mechanisms advocated by the World Bank. Successive phases involved inputs from institutions including Indian Council of Medical Research, National Health Mission, Central Tuberculosis Division and collaborations with international donors like United States Agency for International Development and KfW. National policy adjustments interacted with landmark events such as the 1990 World Summit for Children and frameworks from Stop TB Partnership.

Objectives and Strategy

Primary objectives mirrored targets set by World Health Organization and Stop TB Partnership: reduce tuberculosis prevalence and mortality, interrupt transmission, and prevent drug resistance. Strategic pillars emphasized case detection through sputum microscopy centres established under District Health System structures, standardized treatment using regimens consistent with DOTS strategy principles, supply chain strengthening with support from Central Medical Stores Department models, and surveillance aligned with standards from Global Fund to Fight AIDS, Tuberculosis and Malaria. The programme prioritized vulnerable populations reached through coordination with agencies such as National AIDS Control Organisation, Ministry of Labour and Employment, and state-level bodies.

Organisation and Implementation

Implementation relied on a hierarchical architecture: national oversight by the Central Tuberculosis Division within the Ministry of Health and Family Welfare, state coordination via State TB Cells, and district-level delivery through District TB Centres. Human resources training engaged institutions including All India Institute of Medical Sciences, Christian Medical College, Vellore, and Public Health Foundation of India. Laboratory networks featured designated microscopy centres linked to reference laboratories such as National Institute of Tuberculosis and Respiratory Diseases and regional medical colleges. Partner NGOs and private sector actors—ranging from Indian Medical Association members to corporate health programmes—were integrated through Public-Private Mix initiatives modeled on collaborations used by World Health Organization projects.

Diagnosis and Treatment Protocols

Diagnostic algorithms combined sputum smear microscopy, chest radiography at district hospitals, and later molecular tests recommended by World Health Organization such as Xpert MTB/RIF cartridges procured through national tenders influenced by Global Fund procurement practices. Treatment regimens followed standardized short-course chemotherapy aligned with DOTS strategy: intensive and continuation phases using first-line drugs consistent with drug-sensitivity frameworks from Indian Council of Medical Research. Management of drug-resistant cases invoked second-line regimens and referral to specialized centres modelled after National Institute for Research in Tuberculosis and international protocols from World Health Organization and Centers for Disease Control and Prevention. Recording used standardized treatment cards and reporting forms analogous to those developed by World Health Organization.

Monitoring, Evaluation, and Impact

Monitoring systems combined routine surveillance from district reporting to national aggregates compiled by the Central Tuberculosis Division and epidemiological inputs from Indian Council of Medical Research surveys. External evaluations drew on methods used in Demographic and Health Surveys and collaborated with partners such as World Health Organization and Global Fund. Impact indicators included case detection rates, treatment success rates, and declining mortality metrics comparable to those reported in WHO Global Tuberculosis Report syntheses. Operational research supported by institutions such as Public Health Foundation of India and All India Institute of Medical Sciences informed iterative policy revisions.

Challenges and Criticisms

Critiques paralleled global debates involving World Health Organization and Stop TB Partnership stakeholders: under-detection in urban slums linked to migration patterns studied by National Sample Survey Office methodologies; private sector engagement shortfalls noted by Indian Medical Association surveys; and emergence of multidrug-resistant tuberculosis raising concerns echoed by World Health Organization and Centers for Disease Control and Prevention. Logistical bottlenecks in diagnostics resembled procurement challenges highlighted in Global Fund reviews, while financing constraints prompted comparisons with health financing reforms spearheaded by National Health Mission and fiscal analyses influenced by Reserve Bank of India reports. Academic critiques from Indian Council of Medical Research collaborators and civil society organizations called for stronger integration with broader social determinants addressed in reports by United Nations Development Programme and World Bank studies.

Category:Tuberculosis control